CGEN Stock Price Chart
Daily OHLCV with technical indicators — pan, zoom, and customize your view
04
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance
Revenue, net income, margins and EPS trends
06
Revenue$73M2016-12-31 → 2025-12-31
EPS$0.382016-12-31 → 2025-12-31
Free Cash Flow$31M2016-12-31 → 2025-12-31
Net margin48.6%2016-12-31 → 2025-12-31
Valuation & Ratios07–12
Valuation
P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
CGEN
5Y avg
Peer Median
Verdict
P/E
6.15Y avg ≈-5.5
≈-5.5
·
·
P/S
3.05Y avg ≈16.5
≈16.5
·
·
P/B
2.15Y avg ≈2.2
≈2.2
·
·
Price / FCF
7.05Y avg ≈-3.1
≈-3.1
·
·
Price / Cash Flow
6.95Y avg ≈-3.1
≈-3.1
·
·
Price / Tangible Book
2.15Y avg ≈2.2
≈2.2
·
·
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability
Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
CGEN
5Y avg
Peer Median
Verdict
Gross Margin
87.3%5Y avg ≈85.7%
≈85.7%
64.8%
Top tier
Operating Margin
43.0%5Y avg ≈-221.1%
≈-221.1%
7.3%
Top tier
EBITDA Margin
43.0%5Y avg ≈-221.1%
≈-221.1%
7.9%
Top tier
Pretax Margin
48.6%5Y avg ≈-206.8%
≈-206.8%
0.48%
Top tier
Net Profit Margin
48.6%5Y avg ≈-215.6%
≈-215.6%
-4.3%
Top tier
ROA
26.0%5Y avg ≈-11.7%
≈-11.7%
-28.9%
Top tier
ROE
44.8%5Y avg ≈-14.3%
≈-14.3%
26.2%
Top tier
ROIC
30.4%5Y avg ≈-23.2%
≈-23.2%
-39.8%
Top tier
Financial Health
Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
CGEN
5Y avg
Peer Median
Verdict
Current Ratio
6.65Y avg ≈6.1
≈6.1
5.3
Strong liquidity
Quick Ratio
4.45Y avg ≈2.2
≈2.2
3.8
Strong liquidity
Growth
Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Per Share Metrics
EPS, book value per share, cash flow per share, dividend per share
Metric
5Y trend
CGEN
5Y avg
Peer Median
Verdict
EPS (Diluted)
$0.385Y avg ≈$-0.16
≈$-0.16
·
·
Revenue / Share
$0.785Y avg ≈$0.33
≈$0.33
·
·
Cash Flow / Share
$0.345Y avg ≈$-0.04
≈$-0.04
·
·
Cash / Share
$0.965Y avg ≈$0.31
≈$0.31
·
·
Capital Efficiency
Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
CGEN
5Y avg
Peer Median
Verdict
Asset Turnover
0.55Y avg ≈0.2
≈0.2
0.5
Top tier
Revenue / Employee
≈$970.2K
·
·
·
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History
EPS actual vs estimate, surprise %, beat rate, next earnings date
14
Avg Surprise173.4%
Next ReportNov 09, 2026
Period
Report
EPS Actual
EPS Est
Surprise
June 30, 2026
Aug 11, 2026
$-0.07
$-0.08
14.2%
March 31, 2026
May 18, 2026
$-0.08
$-0.07
-8.1%
Dec. 31, 2025
$0.60
$0.05
1076.5%
Sept. 30, 2025
$-0.07
$-0.09
20.8%
June 30, 2025
$-0.08
$-0.07
-20.7%
March 31, 2025
$-0.08
$-0.06
-42.6%
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
15
Income Statement16
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue
$73M
$28M
$33M
$8M
$6M
$2M
·
$18M
·
$712.0K
$9M
$12M
Cost of Revenue
$9M
$8M
$2M
$975.0K
$680.0K
$60.0K
·
$1M
·
$223.0K
$2M
$3M
Gross Profit
$64M
$20M
$31M
$7M
$5M
$2M
·
$17M
·
$489.0K
$8M
$9M
R&D Expense
$23M
$25M
$34M
$31M
$29M
$23M
$20M
$30M
$29M
$25M
$21M
$15M
SG&A Expense
$9M
$9M
$10M
$10M
$11M
$10M
$8M
$8M
$8M
$7M
$6M
$5M
Operating Expenses
$32M
$35M
$44M
$42M
$40M
$33M
$29M
$40M
$37M
$33M
$29M
$21M
Operating Income
$31M
$-15M
$-13M
$-35M
$-35M
$-31M
$-29M
$-23M
$-37M
$-33M
$-21M
$-12M
Interest Income
$4M
$3M
$3M
$1M
$894.0K
$2M
$935.0K
$643.0K
$523.0K
$728.0K
$815.0K
$346.0K
Pretax Income
$35M
$-10M
$-10M
$-34M
$-34M
$-30M
$-28M
$-23M
$-37M
$-31M
$-20M
$-11M
Income Tax
$54.0K
$5M
$9M
$58.0K
$0
$0
$-722.0K
·
·
$20.0K
$390.0K
$360.0K
Net Income
$35M
$-14M
$-19M
$-34M
$-34M
$-30M
$-27M
$-23M
$-37M
$-32M
$-20M
$-11M
EPS (Basic)
$0.38
$-0.16
$-0.21
$-0.39
$-0.41
$-0.37
$-0.43
$-0.41
$-0.72
$-0.62
$-0.40
$-0.23
EPS (Diluted)
$0.38
$-0.16
$-0.21
$-0.39
$-0.41
$-0.37
$-0.43
$-0.41
$-0.72
$-0.62
$-0.40
$-0.26
Shares (Basic)
93,425,341
89,528,031
87,633,298
86,555,628
84,203,971
79,591,187
63,636,673
55,277,428
51,179,694
50,855,908
50,437,040
47,808,855
Shares (Diluted)
93,815,083
89,528,031
87,633,298
86,555,628
84,203,971
79,591,187
63,636,673
55,277,428
51,179,694
50,855,908
50,437,040
48,387,063
EBITDA
$31M
$-15M
$-13M
$-35M
$-35M
$-31M
$-29M
$-23M
$-37M
$-33M
$-21M
$-12M
Balance Sheet20
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Cash & Equivalents
$91M
$18M
$14M
$11M
$8M
$7M
$9M
$6M
$25M
$10M
$11M
$26M
Short-term Investments
$9M
$24M
$12M
$0
·
·
·
·
·
·
$426.0K
$1M
Receivables
·
$0
$61M
$0
·
$2M
·
·
·
·
$8M
·
Prepaid Expense
$2M
$3M
$3M
$2M
$5M
$3M
$1M
$903.0K
$741.0K
$1M
$1M
$716.0K
Other Current Assets
$144.0K
$142.0K
$226.0K
$232.0K
$131.0K
$122.0K
$306.0K
$58.0K
·
·
$114.0K
$16.0K
Current Assets
$148M
$106M
$115M
$86M
$123M
$129M
$45M
$47M
$31M
$63M
$91M
$75M
PP&E (Net)
$681.0K
$852.0K
$1M
$2M
$2M
$2M
$2M
$3M
$5M
$6M
$6M
$3M
PP&E (Gross)
$7M
$7M
$7M
$8M
$8M
$7M
$7M
$10M
$10M
$9M
$8M
$12M
Accum. Depreciation
$6M
$6M
$5M
$6M
$6M
$5M
$5M
$6M
$5M
$3M
$2M
$9M
Total Assets
$157M
$115M
$121M
$94M
$132M
$138M
$54M
$53M
$39M
$71M
$99M
$115M
Accounts Payable
$2M
$2M
$4M
$2M
$5M
$1M
$1M
$3M
$3M
$1M
$2M
$1M
Accrued Liabilities
$6M
$5M
$8M
·
·
·
·
·
·
·
·
·
Current Liabilities
$23M
$20M
$26M
$12M
$17M
$11M
$7M
$10M
$6M
$5M
$7M
$7M
Capital Leases
$2M
$2M
$719.0K
$1M
$2M
$3M
$3M
·
·
·
·
·
Common Stock
$262.0K
$248.0K
$247.0K
$240.0K
$239.0K
$231.0K
$187.0K
$164.0K
$140.0K
$140.0K
$138.0K
$137.0K
Retained Earnings
$-453M
$-489M
$-475M
$-456M
$-422M
$-388M
$-358M
$-331M
$-308M
$-271M
$-239M
$-219M
AOCI
$8.0K
$11.0K
$2.0K
$0
·
·
·
·
$17.0K
$7.0K
$421.0K
$1M
Stockholders' Equity
$103M
$55M
$66M
$78M
$107M
$120M
$38M
$37M
$29M
$64M
$90M
$106M
Liabilities + Equity
$157M
$115M
$121M
$94M
$132M
$138M
$54M
$53M
$39M
$71M
$99M
$115M
Shares Outstanding
94,553,191
89,541,246
89,237,465
86,624,643
86,433,432
83,675,856
67,922,836
59,849,784
51,293,070
51,131,534
50,572,244
50,254,492
Cash Flow10
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Stock-based Comp
$2M
$3M
$4M
$4M
$4M
$3M
$2M
$2M
$3M
$3M
$4M
$4M
Operating Cash Flow
$32M
$50M
$-36M
$-34M
$-23M
$-28M
$-28M
$-13M
$-31M
$-20M
$-26M
$-11M
CapEx
$306.0K
$118.0K
$172.0K
$477.0K
$292.0K
$166.0K
$155.0K
$158.0K
$385.0K
$3M
$3M
$2M
Investing Cash Flow
$30M
$-46M
$36M
$37M
$7M
$-82M
$5M
$-35M
$46M
$16M
$10M
$-64M
Stock Issued
$11M
$544.0K
$3M
$0
$15M
$74M
$23M
$28M
·
·
·
$71M
Net Stock Activity
$11M
$544.0K
$3M
$0
$15M
$74M
$23M
$28M
·
·
·
$71M
Financing Cash Flow
$11M
$554.0K
$3M
$353.0K
$17M
$108M
$26M
$28M
$201.0K
$2M
$972.0K
$72M
Net Change in Cash
$72M
$4M
$3M
$3M
$704.0K
·
·
·
$16M
$-1M
$-14M
$-3M
Taxes Paid
$55.0K
$14M
$12.0K
·
·
·
·
·
·
$20.0K
·
$360.0K
Free Cash Flow
$31M
$49M
$-36M
$-35M
$-23M
$-28M
$-28M
$-13M
$-31M
$-22M
$-29M
$-13M
Profitability8
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Gross Margin
87.3%
71.5%
94.0%
87.0%
88.7%
97.0%
·
94.2%
·
68.7%
82.4%
73.0%
Operating Margin
43.0%
-53.4%
-38.8%
-471.6%
-584.6%
-1574.8%
·
-130.5%
·
-4576.3%
-225.5%
-99.8%
Net Margin
48.6%
-51.1%
-56.0%
-449.2%
-570.0%
-1484.9%
·
-127.0%
·
-4425.0%
-217.3%
-89.7%
Pretax Margin
48.6%
-34.8%
-29.2%
-448.5%
-570.0%
-1484.9%
·
-127.0%
·
-4422.2%
-213.1%
-86.8%
EBITDA Margin
43.0%
-53.4%
-38.8%
-471.6%
-584.6%
-1574.8%
·
-130.5%
·
-4576.3%
-225.5%
-99.8%
ROA
26.0%
-12.0%
-17.4%
-29.8%
-25.3%
-30.9%
-51.1%
-49.2%
-67.5%
-37.0%
-18.8%
-12.9%
ROE
44.8%
-23.6%
-26.2%
-36.5%
-30.2%
-37.6%
-72.4%
-67.9%
-79.9%
-41.1%
-20.6%
-16.1%
ROIC
30.4%
-39.8%
-38.0%
-45.6%
·
·
-73.4%
·
·
-51.3%
-23.7%
-12.0%
Liquidity & Solvency2
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Current Ratio
6.6
5.3
4.4
7.2
7.2
12.3
6.6
4.7
5.0
13.2
13.3
11.4
Quick Ratio
4.4
2.1
3.3
0.9
0.5
0.9
1.3
0.6
4.1
2.0
2.8
4.1
Efficiency2
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Asset Turnover
0.5
0.2
0.3
0.1
0.0
0.0
·
0.4
·
0.0
0.1
0.1
Receivables Turnover
·
0.9
1.1
·
·
2.0
·
·
·
·
2.4
·
Per Share5
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Book Value / Share
$1.09
$0.61
$0.73
$0.90
$1.23
$1.43
$0.56
$0.62
$0.57
$1.24
$1.78
$2.11
Revenue / Share
$0.78
$0.31
$0.38
$0.09
$0.07
$0.03
·
$0.32
·
$0.01
$0.18
$0.26
Cash Flow / Share
$0.34
$0.55
$-0.41
$-0.40
$-0.27
$-0.36
$-0.44
$-0.24
$-0.60
$-0.39
$-0.51
$-0.23
Cash / Share
$0.96
$0.20
$0.16
$0.13
$0.09
$0.09
$0.14
$0.10
$0.50
$0.19
$0.21
$0.51
EPS (TTM)
$0.38
$-0.16
$-0.21
$-0.39
$-0.41
$-0.37
$-0.43
$-0.41
$-0.72
$-0.62
$-0.40
$-0.26
Valuation (TTM)10
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Revenue TTM
$73M
$28M
$33M
$8M
$6M
$2M
·
$18M
·
$712.0K
$9M
$12M
Net Income TTM
$35M
$-14M
$-19M
$-34M
$-34M
$-30M
$-27M
$-23M
$-37M
$-32M
$-20M
$-11M
Market Cap
$145M
$137M
$177M
$62M
$372M
$1.01B
$405M
$130M
$128M
$261M
$323M
$419M
P/E
4.0
-9.6
-9.4
-1.8
-10.5
-32.7
-13.9
-5.3
-3.5
-8.2
-16.0
-32.0
P/S
2.0
4.9
5.3
8.3
61.9
506.7
·
7.3
·
366.3
34.8
33.8
P/B
1.4
2.5
2.7
0.8
3.5
8.5
10.6
3.5
4.4
4.1
3.6
3.9
P / Tangible Book
1.4
2.5
2.7
0.8
3.5
8.5
·
·
·
·
·
·
P / Cash Flow
4.6
2.8
-4.9
-1.8
-16.3
-35.8
-14.5
-9.8
-4.2
-13.2
-12.6
-37.6
P / FCF
4.6
2.8
-4.9
-1.8
-16.1
-35.6
-14.4
-9.7
-4.1
-11.6
-11.2
-32.1
Earnings Yield
24.8%
-10.5%
-10.6%
-54.2%
-9.5%
-3.1%
-7.2%
-18.9%
-28.8%
-12.2%
-6.3%
-3.1%
Per Share1
Metric
Trend
Q4 2019
Q4 2010
Q4 2009
Q4 2008
Q4 2007
Q4 2006
Q4 2004
Q4 2003
Q4 2002
Q4 2001
EPS (TTM)
$-0.43
·
·
·
·
·
·
·
·
·
Valuation (TTM)4
Metric
Trend
Q4 2019
Q4 2010
Q4 2009
Q4 2008
Q4 2007
Q4 2006
Q4 2004
Q4 2003
Q4 2002
Q4 2001
Revenue TTM
·
$1M
$250.0K
·
·
·
·
·
·
·
Net Income TTM
$-27M
$-7M
$-4M
·
·
·
·
·
·
·
P/E
-13.9
·
·
·
·
·
·
·
·
·
Earnings Yield
-7.2%
·
·
·
·
·
·
·
·
·
Most recent period on the left · null values shown as ·
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
16
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Revenue
$73M
$28M
$33M
$8M
$6M
Gross Margin %
87.3%
71.5%
94.0%
87.0%
88.7%
Operating Margin %
43.0%
-53.4%
-38.8%
-471.6%
-584.6%
Net Income
$35M
$-14M
$-19M
$-34M
$-34M
Diluted EPS
$0.38
$-0.16
$-0.21
$-0.39
$-0.41
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Current Ratio
6.6
5.3
4.4
7.2
7.2
Quick Ratio
4.4
2.1
3.3
0.9
0.5
Metric
2025-12-31
2024-12-31
2023-12-31
2022-12-31
2021-12-31
Free Cash Flow
$31M
$49M
$-36M
$-35M
$-23M
Institutional owners (13F)
88 filers
· $31.3M total
· As of June 30, 2026
17
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders88
Value held$31.3M
New positions17
Exited positions11
Institutional activity — Q2 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
17 (+2 vs prior Q)
11 (+6 vs prior Q)
15 (-2 vs prior Q)
22 (+5 vs prior Q)
+72K
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
Filer
Filed
Stake
Status
Purpose
Filing
SS OR IRS IDENTIFICATION NO. OF ABOVE PERSON Martin S. Gerstel 2)
Clal Biotechnology Industries Ltd. (no U.S. I.D. number), Clal Industries and Investments Ltd. (no U.S. I.D. number), IDB Development Corporation Ltd. (no U.S. I.D. number), IDB Holding Corporation Ltd. (no U.S. I.D. number), Nochi Dankner, Shelly Dankner-Bergman, Avraham Livnat, Ruth Manor
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders
12 insiders
· 6 officers · 7 directors